India, March 25 -- Eye care firm Alcon Inc.(ALC) announced Tuesday that Vivity, an extended depth of focus or EDOF intraocular lens or IOL, is now available on the company's most advanced lens material-Clareon.
Clareon Vivity IOL has received CE Mark approval, and the company plans to commence its commercial rollout in Europe from early second quarter, expanding visual possibilities.
With Vivity, patients with certain mild comorbidities-such as age-related macular degeneration or AMD, retinopathy/maculopathy, glaucoma, and dry eye-as well as those with post-refractive eyes, can successfully receive presbyopia-correcting IOLs, the company noted.
Clareon Vivity leverages a wavefront-shaping optical principle, trademarked as X-WAVE Technolo...